Skip to content

Mahickra Chemicals Ltd. (MAHICKRA)

SME Cap

Industrials stocks · SME cap · NSE

Mahickra Chemicals Ltd. operates in Dyes, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.

₹262.25
-8.75 · -3.23%
Market cap ₹281 Cr
Data qualityFresh enough for analysisQuote updated 21 Oct, 03:31 pm IST
Details
Quote21 Oct, 03:31 pm IST
Base fundamentals18 Oct 2026 · screener
Latest result01 Jun, 07:55 pm IST
Score21 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags24 Apr 2026
Coverage13/14 · 93%
Valuation2026-07-20 · Rf 6.8% · Industrials P/E 26.2 (n=537)
Technical timing lens

Trend score and candlestick chart

54Neutral

SMA20 +4.8% / mo · MACD −

Stock trend: 59
Sector RS: 46
Sector 3M: -7.1% vs Nifty 500 -5.6%

Latest mapped FPI equity flow was not positive. View sector evidence

Technical chart

MAHICKRAD candles · FIT view+12.8%
Latest close ₹262.25 on 2026-10-21
Bar
-5.7%
RSI
38
MACD hist
-4.36
52W pos
72%
Visible chart range
Candle interval
2026-10-21O ₹278.00H ₹278.00L ₹255.00C ₹262.25Vol 5,250 sh
₹200.17₹230.12₹260.06₹290.00₹319.9452H₹262.25VolRSIMACD2026-042026-062026-082026-092026-11
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context

Relative performance and chart statistics

Adjusted completed-session prices, rebased to 100

MAHICKRANifty India ManufacturingNifty 500
-11%+2%+14%+27%21 Jul28 Aug21 Oct21 Oct 2026MAHICKRA +3.4%Nifty India Manufactu… -7.7%Nifty 500 -6.5%
MAHICKRA
+3.4%
Nifty 500
-6.5%
Nifty India Manufacturing
-7.7%
Vs Nifty 500
+9.9 pp
Chart stats
21 Oct 2026
From 52W high
-16.6%
₹314.5
52W range position
72%
₹127.3 - ₹314.5
ATR (14)
5.5%
₹14.3
Volume vs 20D
1.08x
Latest completed session
Avg traded value
₹0.1 Cr
20-session average
20D price channel
₹255 - ₹314.5
45.5% annualized volatility
Research snapshot

What the evidence says now

Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is weak.

Suggested next step
Check latest quarters
Result consistency is weak; verify whether the thesis is improving or deteriorating.
U-Score
Legacy · OVERVALUED
23

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Latest result
Excellent
100

Revenue +62.9% · PAT +300.0% YoY

Technical
Neutral
54

Price trend and sector-relative-strength timing.

Valuation
Legacy model
-26.6%

Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.

Trust
Limited evidence
56

Financial-only signal; management claim evidence is not sufficient yet.

Financials

Fundamentals, quarterly history, margins, returns and balance-sheet evidence

Latest result

Quarter ended 31 Mar 2026

Excellent · 100/100

Rev +63% YoY · PAT +300% YoY · margin expansion · +16% QoQ · operating leverage

Filed 31 Mar 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹57 Cr+62.9%+16.3%
EBITDA₹6 CrNDF+500.0%
Operating margin11.0%NDF+800 bps
PAT₹4 Cr+300.0%+300.0%
PAT margin7.0%NDF+498 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Fundamentals

Valuation

P/E
54.50
P/B
4.20
EV/EBITDA
37.13
Market Cap
281.00Cr

Profitability

ROE
10.00%
ROCE
12.70%
ROA
5.15%
Dividend Y
0.05%

Growth (CAGR)

Revenue 5Y
27.00%
EPS 5Y
27.00%
Revenue 3Y
1.00%
EPS 3Y
15.00%

Balance Sheet

Debt/Equity
0.24
Interest Coverage
4.00×
Altman Z
8.06
Book Value
68.40

Cash Flow

FCF Yield
—
FCF Positive Y
2/5
OCF
-8.00 Cr
EPS TTM
5.27

Shareholding

Promoter Hold
40.10%
Promoter Pledge
0.00%
Momentum 52W
85%

Financial History

Updated 21/10/2026

Revenue

₹ Cr
Latest: 57.0+16.3% vs prev
060.0Mar 2022: 60.0Sep 2022: 54.0Mar 2023: 49.0Sep 2023: 37.0Mar 2024: 35.0Sep 2024: 45.0Mar 2025: 43.0Sep 2025: 49.0Mar 2026: 57.0FY22Q2 22FY23Q2 23FY24Q2 24FY25Q2 25FY26

Net Profit

₹ Cr
Latest: 4.0+300.0% vs prev
04.0Mar 2022: 2.0Sep 2022: 2.0Mar 2023: 2.0Sep 2023: 0.0Mar 2024: 1.0Sep 2024: 1.0Mar 2025: 1.0Sep 2025: 1.0Mar 2026: 4.0FY22Q2 22FY23Q2 23FY24Q2 24FY25Q2 25FY26
ROE is shown only in the Annual view — quarterly equity data isn't published.

Technicals

Trend interpretation, Stage 2, relative strength, volume and indicator evidence

Daily technical trend read

Mixed signals

Signals are conflicting — long-term uptrend intact. RSI 38. Wait for confirmation.

  • Price above SMA200 (long-term uptrend) but mid-term MAs not aligned.
  • SMA20 rising (~4.6% over last month) — short-term momentum positive.
  • RSI(14) at 38 — falling, no extreme reading.
  • MACD below signal, histogram expanding negatively — bearish momentum building.
  • 17% off 52W high · 100% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Nifty 500 leadership

Relative Strength & Trend Stage

92
RS percentile
Stage 2 UptrendEstablished S2
1M return
-11.1%
3M return
+5.7%
6M return
+24.6%
1Y return
+83.3%
RS 1D
0
RS 20D
-2
Sector rank
#2
Industry rank
#6
Stage evidence
  • Price is 8.6% above the 30-week proxy.
  • The 50-DMA is above the 30-week proxy and its slope is rising +7.5%.
  • Both 3-month and 6-month returns are positive.
50-DMA
price below
200-DMA
price above
S2 entered
19 Jan 2026
S2 age
164 trading sessions
Sector
leading
Industry
leading
Relative-strength line vs Nifty 500 (base 100)
217 observations
21 Oct 2026Value 172.83-2.33%
78110142174206Sept 25Feb 26Jun 26Oct 26173
RS vs Nifty 500173

Valuation & peers

U-Score 23 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies

23U-SCORE
OVERVALUED

Fundamental score breakdown

U band · OVERVALUED
Valuation0/30
Growth12/25
Quality4/20
Balance Sheet6/15
Cash Flow1/10
Piotroski
5/9 (+3)
Penalties
-3
Raw sum
23

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

23/100 · legacy band OVERVALUED

Positive drivers

  • Growth contributes 12/25 to the score.
  • Balance sheet contributes 6/15 to the score.
  • Quality contributes 4/20 to the score.

Main drags

  • Penalty bucket subtracts 3 points.
  • Fair-value margin of safety is negative at -26.6%.
  • Valuation is weaker at 0/30; verify the latest quarterly trend.
Sector valuation model

Cyclical valuation: normalized earnings, not just trailing PE

Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.

Cyclical normalized
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
54.5
PB
4.2
EV/EBITDA
37.1
ROE
10.0%
ROCE
12.7%
FCF Yield
—
Debt/Equity
0.2
MoS
-26.6%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 21 Oct 2026
v4.3-runtime-valuation
Final score
23
Previous: 23
Legacy U-Score band
OVERVALUED
Previous: OVERVALUED
Margin of safety
-26.6%
Previous: -30.8%

Score history

12 stored score snapshots. Latest stored move: +0 points.

21 Oct 2026
v4.3-runtime-valuation
23
23
23
23
23
23
23
23
23
23
23
23

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.

Modelled fair value

Graham Number
₹90.06
-191.2% MoS
Growth-justified P/E
39.3
Growth-justified Value
₹207.11
-26.6% MoS
PEG
2.45

Comparable companies

Peers

Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.

Compare all ↗
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
UCL
SME
Ushanti Colour Chem Ltd.
Specialty Chemicals
match 167
15
—
-0.8%
—
OVERVALUED
SRD
Small
Shankar Lal Rampal Dye-Chem Limited
Specialty Chemicals
match 159
49
13.2
11.6%
+71%
FAIR VALUE
BODALCHEM
Small
Bodal Chemicals Limited
Specialty Chemicals
match 144
26
33.0
2.0%
-770%
OVERVALUED
BHAGERIA
Small
Bhageria Industries Limited
Specialty Chemicals
match 144
28
23.0
7.0%
-421%
OVERVALUED
SPEB
SME
Speb Adhesives Ltd.
Specialty Chemicals
match 135
48
28.1
16.9%
+31%
FAIR VALUE

Business, management & trust

Growth engines, risks, management commitments and evidence-backed delivery

Business and thesis

Issuer presentation review pending

Mahickra Chemicals Ltd. operates in Dyes, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 31 Mar 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.

Trust Score
56Limited evidence · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Limited evidence: Claim history is still being built. It ranks around the 18th percentile of the scored universe and 14th percentile within Industrials. Main check: results consistency is weak at 27/100.

This is a financial-behaviour screen, not a claim-tested management reliability verdict.

Computed 05 Sept 2026
management-trust-v1
0 docs text-extracted · 0 concalls text-extracted
Score band
Limited evidence

Financial behaviour is scored, but management claims do not yet have enough outcome checks.

Relative rank
18th percentile

overall median 67 · Industrials: 14th pctile, median 68 · SME: 19th pctile, median 64

Evidence depth
Financial-only

0 documents have extracted text, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Limited evidence · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Needs extra due diligence; demand valuation comfort and recent improvement.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
60
acceptable · holding, pledge, alignment
Cash flow
40
weak · profit to cash conversion
Balance sheet
81
strong · leverage and solvency
Discipline
68
acceptable · capital discipline
Results
27
weak · quarterly consistency

Trust positives

  • ▸Promoter pledge is zero.

Trust risks

  • ▸Promoter holding fell 11.7%.
  • ▸Operating cash flow is negative at ₹-8 Cr.
  • ▸3 latest quarters had PAT decline worse than 25% YoY.
  • ▸1/4 latest quarters had positive YoY PAT growth.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Important announcements & filings

Latest exchange and company disclosures found within the past two years.

4 shown
Annual reportSep 2026

Sep 2026 · General Updates 5 Sep - Mahickra Chemicals shares FY26 annual report link and AGM notice for September 30, 2026.

Source: Nse

Open source ↗
Annual reportSep 2026

Sep 2026 · Shareholders meeting 5 Sep - Mahickra Chemicals schedules 9th AGM on September 30, 2026; annual report and e-voting dates disclosed.

Source: Nse

Open source ↗
Annual reportMar 2026

Mar 2026 · Annual Report 2026

Source: Nse

Open source ↗
Annual reportMar 2025

Mar 2025 · Annual Report 2025

Source: Nse

Open source ↗
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.